PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice

BACKGROUND: In practice, prescribing of a GLP-1 agonist (GLP-1a) or SGLT-2 inhibitor (SGLT-2i) for patients with type 2 diabetes mellitus (T2DM) and multiple risk factors for atherosclerotic cardiovascular disease (ASCVD) may be lagging behind the guidelines that recommend it. We aim to increase the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuetz, Samantha, Carson, Elizabeth, Gilbert, Matthew, Gogerly-Moragoda, Ruveni, Sobel, Halle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Diabetes & Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629331/
http://dx.doi.org/10.1210/jendso/bvac150.770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629331/
http://dx.doi.org/10.1210/jendso/bvac150.770

Ejemplares similares